GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Horizon Pharma Inc (HZNP) [hlAlert]

Horizon Pharma, Inc. (Horizon) is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501),
a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company?s other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company?s distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation.
( Total: 9 Current Stock Recommendations )
Horizon Pharma Inc   (9)
Sell Hold Buy 78%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Buy HZNP
up 39.59 %

Rating:
Hold HZNP
Horizon Pharma Inc (HZNP) rated Neutral by Citigroup
Wednesday,  Jan 6, 2016  10:25 AM ET

Rating:
Sell HZNP
down 31.23 %

Rating:
Buy HZNP
up 39.59 %
Horizon Pharma Inc (HZNP) rated Buy by Jefferies
Monday,  Nov 23, 2015  10:25 AM ET

Rating:
Buy HZNP
up 267.30 %
Horizon Pharma Inc (HZNP) rated Mkt Outperform by JMP Securities
Wednesday,  Sep 9, 2015  10:25 AM ET

Rating:
Buy HZNP
up 18.92 %

Rating:
Buy HZNP
up 18.92 %
Horizon Pharma Inc (HZNP) rated Buy with price target $30 by UBS
Tuesday,  Mar 31, 2015  1:25 PM ET

Rating:
Buy HZNP
up 112.83 %

Rating:
Buy HZNP
up 267.30 %

Rating:
Buy HZNP
up 843.69 %

Rating:
Buy HZNP
up 267.30 %

Rating:
Buy HZNP
up 843.69 %

Rating:
Buy HZNP
up 630.23 %

Rating:
Buy HZNP
up 843.69 %

Rating:
Hold HZNP
Horizon Pharma Inc (HZNP) rated Neutral by Piper Jaffray
Friday,  Jan 4, 2013  8:25 AM ET

Your Recent Stocks
SymbolLastChange
HZNP 18.33 down  -40.23 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy